E3 Ubiquitin Protein Ligase Mdm2 Pipeline Review Market H2 2016 E3 Ubiquitin Protein Ligase Mdm2 Market 2016

Early Stage Products 14 E3 Ubiquitin Protein Ligase Mdm2 (Double Minute 2 Protein or Hdm2 or Oncoprotein Mdm2 or p53 Binding Protein Mdm2 or MDM2 or EC 6.3.2.) - Products under Development by Companies 15 E3 Ubiquitin Protein Ligase Mdm2 (Double Minute 2 Protein or Hdm2 or Oncoprotein Mdm2 or p53 Binding Protein Mdm2 or MDM2 or EC 6.3.2.) - Products under Development by Universities/Institutes 19 E3 Ubiquitin Protein Ligase Mdm2 (Double Minute 2 Protein or Hdm2 or Oncoprotein Mdm2 or p53 Binding Protein Mdm2 or MDM2 or EC 6.3.2.) - Therapeutics Assessment 21 Assessment by Monotherapy/Combination Products 21 Assessment by Mechanism of Action 22 Assessment by Route of Administration 23 Assessment by Molecule Type 25 E3 Ubiquitin Protein Ligase Mdm2 (Double Minute 2 Protein or Hdm2 or Oncoprotein Mdm2 or p53 Binding Protein Mdm2 or MDM2 or EC 6.3.2.) - Companies Involved in Therapeutics Development 27 Read Complete Report With TOC @ http://www.radiantinsights.com/research/e3-ubiquitinprotein-ligase-mdm2 Aileron Therapeutics, Inc. 27 Amgen Inc. 28 Ascentage Pharma Group Corporation, Ltd. 29 Daiichi Sankyo Company, Limited 30 F. Hoffmann-La Roche Ltd. 31 Merck & Co., Inc. 32 Novartis AG 33 E3 Ubiquitin Protein Ligase Mdm2 (Double Minute 2 Protein or Hdm2 or Oncoprotein Mdm2 or p53 Binding Protein Mdm2 or MDM2 or EC 6.3.2.) - Drug Profiles 34 ALRN-6924 - Drug Profile 34 Product Description 34 Mechanism Of Action 34

E3 Ubiquitin Protein Ligase Mdm2 Pipeline Review Market H2 2016 E3 Ubiquitin Protein Ligase Mdm2 Market 2016 | Page 4